このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
OPTUS Pharmaceutical マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Dong-Hwa Han
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | no data |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | データなし |
経営陣の近況
Recent updates
There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump
Jun 27
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence
Apr 05DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit
Mar 09DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 10
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 12Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?
Dec 08CEO（最高経営責任者
Dong-Hwa Han
no data
在職期間
Mr. Dong-Hwa Han serves as the Chief Executive Officer and President of OPTUS Pharmaceutical Co., Ltd. (formerly known as DHP Korea Co., Ltd.) (formerly known as DHP Korea Ltd.).